Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma : case report and review of literature
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-01-01
著者
-
Usmani Saad
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
MUZAFFAR Jameel
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
KATRAGADDA Lakshmikanth
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
HAIDER Sajjad
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
JAVED Ali
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
ANAISSIE Elias
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences
-
Muzaffar Jameel
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Katragadda Lakshmikanth
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Anaissie Elias
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Javed Ali
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences
-
Haider Sajjad
Myeloma Institute For Research And Therapy University Of Arkansas For Medical Sciences